FDA finalized efforts to streamline the process used by physicians to request expanded access, often called compassionate use, to investigational drugs and biologics, as well as two guidance documents. “As a physician, I understand the importance of being able to access investigational treatments for a patient when there are no other options to treat their...
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
